Scientists test new shot to protect against yellow fever
NCT ID NCT05172544
Summary
This early-stage study tested a new, inactivated yellow fever vaccine in healthy adults to see if it was safe and if it could trigger a protective immune response. Twenty-six participants received either the vaccine or a placebo in two doses, one month apart. The main goal was to monitor for any side effects and measure the body's immune response to the vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YELLOW FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Health System
Durham, North Carolina, 27705, United States
Conditions
Explore the condition pages connected to this study.